Lawrence Kingsley - May 17, 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Lawrence D. Kingsley
Stock symbol
IDXX
Transactions as of
May 17, 2023
Transactions value $
$0
Form type
4
Date filed
5/19/2023, 05:03 PM
Previous filing
May 15, 2023
Next filing
Jun 7, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award $0 +645 $0.00 645 May 17, 2023 Common Stock 645 $487.12 Direct F1
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award $0 +206 +31.94% $0.00 851 May 17, 2023 Common Stock 206 $487.12 Direct F1, F2
transaction IDXX Restricted Stock Unit Award +257 257 May 17, 2023 Common Stock 257 Direct F3
transaction IDXX Restricted Stock Unit Award +82 +31.91% 339 May 17, 2023 Common Stock 82 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2024 annual meeting of shareholders, whichever event is earlier.
F2 Additional grant made pursuant to reporting person's role as Non-Executive Board Chair.
F3 Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest in in one installment on the one year anniversary of the date of grant or on the date of the 2024 annual meeting of shareholders, whichever event is earlier.